[CLDX] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
03-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -3.12%
YoY- -28.23%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 620 980 97 2,414 3,647 3,113 2,009 -54.23%
PBT -22,062 -23,140 -19,016 -17,332 -16,807 -15,027 -13,362 39.56%
Tax -137 -142 -161 -379 -94 -105 -252 -33.31%
NP -22,062 -23,140 -19,016 -17,332 -16,807 -15,027 -13,773 36.78%
Tax Rate - - - - - - - -
Total Cost 22,682 24,120 19,113 19,746 20,454 18,140 15,782 27.26%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin -3,558.39 -2,361.22 -19,604.12 -717.98 -460.84 -482.72 -685.56 198.88%
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS -3.71 -4.28 -3.53 -3.51 -4.03 -3.79 -3.52 3.55%
EPS Diluted -3.71 -4.28 -3.53 -3.51 -4.03 -3.79 -3.52 3.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.